Gentherm Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Gentherm Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	918	994	1,049	972	913	1,046	1,205	1,469	1,456	1,499
Cost of revenue	623	675	744	683	645	743	931	1,117	1,090	1,136
Gross profit	295	319	305	288	268	304	274	352	366	362
Research and development	72.9	82.5	79.9	72.5	68	75.2	85.7	94.4	88.7	94.8
Selling, general and administrative	115	140	137	119	105	110	133	156	155	170
Operating expenses	189	222	232	204	179	189	225	274	259	279
Operating income	106	97.1	72.8	84.3	89.2	115	48.3	77.4	107	82.7
Other non-operating income	-0.11	0.15	1.13	0.12	2.34	0.12	1.15	-1.93	0.95	-4.64
Pre-tax income	111	69.3	58.1	59.2	81.6	114	38.4	55	102	35.8
Income tax	34	34	16.2	10.3	21.9	20.4	13.9	14.6	37.3	17.6
Net income	76.6	35.2	41.9	48.9	59.7	93.4	24.4	40.3	64.9	18.3
EBITDA	144	142	123	129	130	154	92.7	128	160	136
EPS, basic	2.10	0.96	1.17	1.48	1.83	2.82	0.74	1.23	2.08	0.60
EPS, diluted	2.09	0.96	1.16	1.47	1.81	2.79	0.73	1.22	2.06	0.59
Shares, basic (weighted)	36.4	36.7	35.9	33.1	32.7	33.1	33.1	32.8	31.3	30.6
Shares, diluted (weighted)	36.6	36.8	36.2	33.3	33	33.5	33.5	33.1	31.5	30.9

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	177	103	39.6	50.4	268	191	154	150	134	161
Receivables	170	185	167	160	212	183	247	254	258	281
Inventory	105	121	113	118	122	159	218	206	227	253
Other current assets	32	51.2	54.4	42.7	41.2	32.8	64.6	78.4	64.4	82.3
Total current assets	484	461	443	374	644	566	684	688	684	777
Property, plant and equipment	172	200	171	161	153	155	244	245	253	271
Lease right-of-use assets				11.6	30.6	24.4	29.9	27.4	44	56.5
Goodwill	51.7	69.7	55.3	64.6	68	66	120	104	99.6	109
Intangible assets	57.6	83.3	56.4	49.8	46.4	37.6	73.9	66.5	57.3	52.8
Other non-current assets	40.8	38	12.9	9.33	7.65	16.6	17.5	21.7	34.7	37.1
Total assets	843	883	803	739	1,023	935	1,239	1,234	1,248	1,396
Accounts payable	84.5	89.6	93.1	83	116	123	182	216	227	260
Accrued liabilities	106	77.2	65.8	26	26.6	28.8	32	43.2	42.3	49.9
Short-term debt	2.09	3.46	3.41	2.5	2.5	2.5	2.44	0.62	0.14	0.07
Total current liabilities	194	171	175	157	206	213	286	325	340	404
Long-term debt	169	141	136	78.1	190	36.3	233	222	220	189
Lease liabilities				6.75	24.2	19.8	20.5	16.2	37.1	48.1
Total liabilities	383	330	323	255	437	282	567	590	631	676
Total debt	172	145	140	80.6	192	38.8	235	223	220	189
Retained earnings	257	294	364	413	473	566	591	624	696	714
Other comprehensive income	-69.1	-20.4	-39.5	-42.4	-15	-36.9	-46.5	-30.2	-85.2	-0.96
Shareholders' equity	460	554	480	484	586	654	672	645	617	720
Total equity	460	554	480	484	586	654	672	645	617	720
Total liabilities and equity	843	883	803	739	1,023	935	1,239	1,234	1,248	1,396
Shares outstanding	36.5	36.8	33.9	32.7	32.9	33	33.2	31.5	30.8	30.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	76.6	35.2	41.9	48.9	59.7	93.4	24.4	40.3	64.9	18.3
Depreciation and amortization	37.8	45	50.6	44.2	41.1	38.8	44.4	50.9	53	53.4
Stock-based compensation	9.19	12.5	9.05	6.25	8.83	14.5	6.6	11.6	10.4	12.3
Deferred income tax	-8.84	5.07	6.73	-7.74	0.85	-0.15	-7.32	-13.1	10.6	-22.3
Change in receivables	-18	6.03	3.02	7.15	-46.7	25.1	-44.2	-4.2	-12.1	-9.3
Change in inventory	-5.93	-4.35	-7.69	-3.86	-2.58	-42.4	-40.3	6.91	-34.2	-21.6
Change in payables	4.42	-7.69	12.4	-10.3	30	8.17	28.3	31	16.2	27.6
Cash from operations	108	49.9	118	119	111	143	14.9	119	110	117
Capital expenditures	-66.3	-50.8	-41.5	-23.7	-17.2	-38.5	-39.7	-37.6	-73.3	-55.7
Acquisitions	-73.6	-67	-0.02	-14.8		-2.83	-205
Cash from investing	-144	-118	-40.8	5.84	-18.2	-48.8	-240	-24.1	-53.5	-52.4
Debt issued	115		94.7	37.8	201		207	60	68	112
Debt repaid	-42.2	-27.2	-99.5	-97	-91.4	-153	-13.3	-72.3	-70.6	-143
Stock issued	1.44	2.76	14.8	16.6	16.6	8.28	1.67	0.26	5.79
Share buybacks		-5.33	-148	-63.3	-9.09	-20		-91.1	-51.6	-10
Cash from financing	79.9	-31.6	-139	-109	115	-169	190	-106	-51.7	-42.5
Exchange rate effect					7.44	-2.84	-1.69	6.69	-19.9	4.79
Net change in cash	32.7	-74	-63.6	13.3	215	-77.7	-36.7	-4.22	-15.5	26.7
Free cash flow	42.1	-0.91	76.9	95.1	93.5	105	-24.8	81.7	36.3	61.1
Interest paid	3.03	4.54	5.03	4.46	4.2	2.38	6.34	13.2	13	12.6
Income taxes paid	21.6	76.7	23.2	11	5.01	14.9	21.6	23.3	20.8	37.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $35.21 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	24.0%	Gross profit / revenue.
Operating margin	4.0%	Operating income / revenue.
EBITDA margin	7.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.9%	Pre-tax income / revenue.
Net margin	1.7%	Net income / revenue.
FCF margin	2.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.5%	Cash from operations / revenue.
Effective tax rate	42.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.8%	Net income / average total assets.
Return on invested capital (ROIC)	4.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.1%	Research and development expense / revenue.
SG&A / revenue	12.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	3.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-1.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-22.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	19.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-1.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-14.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	0.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-71.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-9.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-21.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-71.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-6.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-20.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	6.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	98.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	68.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-8.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	16.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	11.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.06x	Current assets / current liabilities.
Quick ratio	1.29x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.50x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.38x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.3%	Total debt / total assets.
Liabilities / assets	51.6%	Total liabilities / total assets.
Net debt	$60.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.50x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$453.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	10.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$566.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.06x	Revenue / average total assets.
Fixed asset turnover	5.88x	Revenue / average property, plant and equipment.
Inventory turnover	4.91x	Cost of revenue / average inventory.
Days inventory	74 days	365 x average inventory / cost of revenue.
Receivables turnover	4.66x	Revenue / average receivables.
Days sales outstanding	78 days	365 x average receivables / revenue.
Days payables	82 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	70 days	Days inventory + days sales outstanding - days payables.
FCF conversion	155.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	52.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.86	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$50.86	Revenue / diluted weighted shares.
FCF per share	$1.33	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.81	Cash from operations / diluted weighted shares.
Book value per share	$23.55	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$18.44	Tangible book value / shares outstanding.
Cash per share	$6.94	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.08B	Share price x shares outstanding.
Enterprise value	$1.14B	Market cap + total debt - cash - short-term investments.
P/E	40.7x	Market cap / net income. Only when net income is positive.
P/S	0.68x	Market cap / revenue.
P/B	1.50x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.91x	Market cap / tangible book value, when positive.
P/FCF	26.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	12.4x	Market cap / cash from operations, when positive.
EV/Sales	0.72x	Enterprise value / revenue.
EV/EBIT	17.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.54x	Enterprise value / EBITDA, when both are positive.
EV/FCF	27.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.8%	Free cash flow / market cap.
Earnings yield	2.5%	Net income / market cap (the inverse of P/E).

What was Gentherm Inc's revenue in fiscal 2025?

Gentherm Inc reported revenue of $1.50B for fiscal 2025, 2.9% higher than the year before.

Was Gentherm Inc profitable in fiscal 2025?

Yes. Net income was $18.3M, a net margin of 1.2%.

How much free cash flow did Gentherm Inc generate in fiscal 2025?

Cash from operations of $116.8M minus capital expenditures of $55.7M left free cash flow of $61.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Gentherm Inc